Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from http://www.ncbi.nlm.nih.gov/pubmed/31986264 below:

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Affiliations

• ¹ Jin Yin-tan Hospital, Wuhan, China.
• ² Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China.
• ³ Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
• ⁴ NHC Key Laboratory of Systems Biology of Pathogens and Christophe Merieux Laboratory, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
• ⁵ Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
• ⁶ Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
• ⁷ Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China; Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
• ⁸ Tsinghua University School of Medicine, Beijing, China.
• ⁹ Department of Respiratory medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
• ¹⁰ Department of Radiology, China-Japan Friendship Hospital, Beijing, China.
• ¹¹ Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
• ¹² Department of Pulmonary and Critical Care Medicine, Peking University First Hospital, Beijing, China.
• ¹³ Department of Pulmonary and Critical Care Medicine, Peking University People's Hospital, Beijing, China.
• ¹⁴ NHC Key Laboratory of Systems Biology of Pathogens and Christophe Merieux Laboratory, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: wangjw28@163.com.
• ¹⁵ Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China; Tsinghua University-Peking University Joint Center for Life Sciences, Beijing, China. Electronic address: caobin_ben@163.com.

• PMID: 31986264
• PMCID: PMC7159299
• DOI: 10.1016/S0140-6736(20)30183-5

Item in Clipboard

Chaolin Huang et al. Lancet. 2020.

• ¹ Jin Yin-tan Hospital, Wuhan, China.
• ² Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China.
• ³ Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
• ⁴ NHC Key Laboratory of Systems Biology of Pathogens and Christophe Merieux Laboratory, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
• ⁵ Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
• ⁶ Department of Pulmonary and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
• ⁷ Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China; Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
• ⁸ Tsinghua University School of Medicine, Beijing, China.
• ⁹ Department of Respiratory medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
• ¹⁰ Department of Radiology, China-Japan Friendship Hospital, Beijing, China.
• ¹¹ Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
• ¹² Department of Pulmonary and Critical Care Medicine, Peking University First Hospital, Beijing, China.
• ¹³ Department of Pulmonary and Critical Care Medicine, Peking University People's Hospital, Beijing, China.
• ¹⁴ NHC Key Laboratory of Systems Biology of Pathogens and Christophe Merieux Laboratory, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: wangjw28@163.com.
• ¹⁵ Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China; Tsinghua University-Peking University Joint Center for Life Sciences, Beijing, China. Electronic address: caobin_ben@163.com.

• PMID: 31986264
• PMCID: PMC7159299
• DOI: 10.1016/S0140-6736(20)30183-5

Item in Clipboard

• Department of Error.

  [No authors listed] [No authors listed] Lancet. 2020 Feb 15;395(10223):496. doi: 10.1016/S0140-6736(20)30252-X. Epub 2020 Jan 30. Lancet. 2020. PMID: 32007144 Free PMC article. No abstract available.

Background: A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients.

Methods: All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan. We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing. Data were obtained with standardised data collection forms shared by WHO and the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. Researchers also directly communicated with patients or their families to ascertain epidemiological and symptom data. Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not.

Findings: By Jan 2, 2020, 41 admitted hospital patients had been identified as having laboratory-confirmed 2019-nCoV infection. Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]). Median age was 49·0 years (IQR 41·0-58·0). 27 (66%) of 41 patients had been exposed to Huanan seafood market. One family cluster was found. Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum production (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38). Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8·0 days [IQR 5·0-13·0]). 26 (63%) of 41 patients had lymphopenia. All 41 patients had pneumonia with abnormal findings on chest CT. Complications included acute respiratory distress syndrome (12 [29%]), RNAaemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died. Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα.

Interpretation: The 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality. Major gaps in our knowledge of the origin, epidemiology, duration of human transmission, and clinical spectrum of disease need fulfilment by future studies.

Funding: Ministry of Science and Technology, Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technology Commission.

Copyright © 2020 Elsevier Ltd. All rights reserved.

PubMed Disclaimer

Date of illness onset and…

Date of illness onset and age distribution of patients with laboratory-confirmed 2019-nCoV infection…

Date of illness onset and age distribution of patients with laboratory-confirmed 2019-nCoV infection (A) Number of hospital admissions by age group. (B) Distribution of symptom onset date for laboratory-confirmed cases. The Wuhan local health authority issued an epidemiological alert on Dec 30, 2019, and closed the Huanan seafood market 2 days later.

Timeline of 2019-nCoV cases after…

Timeline of 2019-nCoV cases after onset of illness

Timeline of 2019-nCoV cases after onset of illness

Chest CT images (A) Transverse…

Chest CT images (A) Transverse chest CT images from a 40-year-old man showing…

Chest CT images (A) Transverse chest CT images from a 40-year-old man showing bilateral multiple lobular and subsegmental areas of consolidation on day 15 after symptom onset. Transverse chest CT images from a 53-year-old woman showing bilateral ground-glass opacity and subsegmental areas of consolidation on day 8 after symptom onset (B), and bilateral ground-glass opacity on day 12 after symptom onset (C).

• A novel coronavirus outbreak of global health concern.

  Wang C, Horby PW, Hayden FG, Gao GF. Wang C, et al. Lancet. 2020 Feb 15;395(10223):470-473. doi: 10.1016/S0140-6736(20)30185-9. Epub 2020 Jan 24. Lancet. 2020. PMID: 31986257 Free PMC article. No abstract available.

• Data sharing and outbreaks: best practice exemplified.

  Heymann DL. Heymann DL. Lancet. 2020 Feb 15;395(10223):469-470. doi: 10.1016/S0140-6736(20)30184-7. Epub 2020 Jan 24. Lancet. 2020. PMID: 31986258 Free PMC article. No abstract available.

• Novel coronavirus is putting the whole world on alert.

  Khan S, Ali A, Siddique R, Nabi G. Khan S, et al. J Hosp Infect. 2020 Mar;104(3):252-253. doi: 10.1016/j.jhin.2020.01.019. Epub 2020 Feb 4. J Hosp Infect. 2020. PMID: 32032614 Free PMC article. No abstract available.

• 2019-nCoV transmission through the ocular surface must not be ignored.

  Lu CW, Liu XF, Jia ZF. Lu CW, et al. Lancet. 2020 Feb 22;395(10224):e39. doi: 10.1016/S0140-6736(20)30313-5. Epub 2020 Feb 6. Lancet. 2020. PMID: 32035510 Free PMC article. No abstract available.

• Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics.

  Zhang J, Zhou L, Yang Y, Peng W, Wang W, Chen X. Zhang J, et al. Lancet Respir Med. 2020 Mar;8(3):e11-e12. doi: 10.1016/S2213-2600(20)30071-0. Epub 2020 Feb 13. Lancet Respir Med. 2020. PMID: 32061335 Free PMC article. No abstract available.

• Full spectrum of COVID-19 severity still being depicted.

  Xu Z, Li S, Tian S, Li H, Kong LQ. Xu Z, et al. Lancet. 2020 Mar 21;395(10228):947-948. doi: 10.1016/S0140-6736(20)30308-1. Epub 2020 Feb 14. Lancet. 2020. PMID: 32066525 Free PMC article. No abstract available.

• Novel coronavirus 2019, an emerging public health emergency.

  Ward MP, Li X, Tian K. Ward MP, et al. Transbound Emerg Dis. 2020 Mar;67(2):469-470. doi: 10.1111/tbed.13509. Epub 2020 Feb 19. Transbound Emerg Dis. 2020. PMID: 32077206 Free PMC article. No abstract available.

• Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19).

  Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Jiang F, et al. J Gen Intern Med. 2020 May;35(5):1545-1549. doi: 10.1007/s11606-020-05762-w. Epub 2020 Mar 4. J Gen Intern Med. 2020. PMID: 32133578 Free PMC article.

• SARS-CoV-2: a potential novel etiology of fulminant myocarditis.

  Chen C, Zhou Y, Wang DW. Chen C, et al. Herz. 2020 May;45(3):230-232. doi: 10.1007/s00059-020-04909-z. Herz. 2020. PMID: 32140732 Free PMC article. No abstract available.

• Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients.

  Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, Dong XQ, Zheng YT. Zheng HY, et al. Cell Mol Immunol. 2020 May;17(5):541-543. doi: 10.1038/s41423-020-0401-3. Epub 2020 Mar 17. Cell Mol Immunol. 2020. PMID: 32203186 Free PMC article. No abstract available.

• Initial Experience of an Emergency Department in Shenzhen in Responding to the Emerging Wuhan Coronavirus Pneumonia.

  Lu KL, Chen S, Leung LP. Lu KL, et al. Ann Emerg Med. 2020 Apr;75(4):556. doi: 10.1016/j.annemergmed.2020.02.006. Ann Emerg Med. 2020. PMID: 32216893 Free PMC article. No abstract available.

• At the 'heart' of the COVID-19 outbreak: early cardiac implications and mitigating strategies.

  Cherian R, Poh KK. Cherian R, et al. Singapore Med J. 2020 Jul;61(7):373-374. doi: 10.11622/smedj.2020042. Epub 2020 Mar 31. Singapore Med J. 2020. PMID: 32227794 Free PMC article. No abstract available.

• Post-donation COVID-19 identification in blood donors.

  Kwon SY, Kim EJ, Jung YS, Jang JS, Cho NS. Kwon SY, et al. Vox Sang. 2020 Nov;115(8):601-602. doi: 10.1111/vox.12925. Epub 2020 Apr 21. Vox Sang. 2020. PMID: 32240537 No abstract available.

• COVID-19 transmission through asymptomatic carriers is a challenge to containment.

  Yu X, Yang R. Yu X, et al. Influenza Other Respir Viruses. 2020 Jul;14(4):474-475. doi: 10.1111/irv.12743. Epub 2020 Apr 15. Influenza Other Respir Viruses. 2020. PMID: 32246886 Free PMC article. No abstract available.

• We Should Not Ignore What Scientific Articles are Telling Us: A Lesson from the Italian COVID-19 Experience.

  Montorsi F. Montorsi F. J Urol. 2020 Jul;204(1):5-6. doi: 10.1097/JU.0000000000001069. Epub 2020 Apr 3. J Urol. 2020. PMID: 32249713 Free PMC article. No abstract available.

• [Taking preventive measures immediately: evidence from China on COVID-19].

  Zhao G. Zhao G. Gac Sanit. 2020 May-Jun;34(3):217-219. doi: 10.1016/j.gaceta.2020.03.002. Epub 2020 Apr 4. Gac Sanit. 2020. PMID: 32265049 Free PMC article. Spanish. No abstract available.

• Sudden and Complete Olfactory Loss of Function as a Possible Symptom of COVID-19.

  Eliezer M, Hautefort C, Hamel AL, Verillaud B, Herman P, Houdart E, Eloit C. Eliezer M, et al. JAMA Otolaryngol Head Neck Surg. 2020 Jul 1;146(7):674-675. doi: 10.1001/jamaoto.2020.0832. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 32267483 No abstract available.

• Analysis of Characteristics in Death Patients with COVID-19 Pneumonia without Underlying Diseases.

  Hu Y, Deng H, Huang L, Xia L, Zhou X. Hu Y, et al. Acad Radiol. 2020 May;27(5):752. doi: 10.1016/j.acra.2020.03.023. Epub 2020 Apr 7. Acad Radiol. 2020. PMID: 32273135 Free PMC article. No abstract available.

• COVID-19 indirect contact transmission through the oral mucosa must not be ignored.

  Zhang Z, Zhang L, Wang Y. Zhang Z, et al. J Oral Pathol Med. 2020 May;49(5):450-451. doi: 10.1111/jop.13019. J Oral Pathol Med. 2020. PMID: 32281674 Free PMC article. No abstract available.

• Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact.

  Cantini F, Niccoli L, Matarrese D, Nicastri E, Stobbione P, Goletti D. Cantini F, et al. J Infect. 2020 Aug;81(2):318-356. doi: 10.1016/j.jinf.2020.04.017. Epub 2020 Apr 23. J Infect. 2020. PMID: 32333918 Free PMC article.

• IL-6 may be a good biomarker for earlier detection of COVID-19 progression.

  Wang C, Fei D, Li X, Zhao M, Yu K. Wang C, et al. Intensive Care Med. 2020 Jul;46(7):1475-1476. doi: 10.1007/s00134-020-06065-8. Epub 2020 May 8. Intensive Care Med. 2020. PMID: 32385523 Free PMC article. No abstract available.

• Descriptive study of COVID-19 outbreak among passengers and crew on Diamond Princess cruise ship, Yokohama Port, Japan, 20 January to 9 February 2020.

  Yamagishi T, Kamiya H, Kakimoto K, Suzuki M, Wakita T. Yamagishi T, et al. Euro Surveill. 2020 Jun;25(23):2000272. doi: 10.2807/1560-7917.ES.2020.25.23.2000272. Euro Surveill. 2020. PMID: 32553062 Free PMC article.

• Potential of regulatory T-cell-based therapies in the management of severe COVID-19.

  Stephen-Victor E, Das M, Karnam A, Pitard B, Gautier JF, Bayry J. Stephen-Victor E, et al. Eur Respir J. 2020 Sep 3;56(3):2002182. doi: 10.1183/13993003.02182-2020. Print 2020 Sep. Eur Respir J. 2020. PMID: 32616599 Free PMC article.

• Women's Sexual Health in COVID-19 Pandemic: Challenges and Solutions.

  Peyravi M, Soltani A, Ahmadi Marzaleh M. Peyravi M, et al. Prehosp Disaster Med. 2020 Dec;35(6):698-699. doi: 10.1017/S1049023X20001107. Epub 2020 Aug 24. Prehosp Disaster Med. 2020. PMID: 32829719 Free PMC article. No abstract available.

• Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia.

  Hsu A, Liu Y, Zayac AS, Olszewski AJ, Reagan JL. Hsu A, et al. Thromb Res. 2020 Dec;196:375-378. doi: 10.1016/j.thromres.2020.09.030. Epub 2020 Sep 23. Thromb Res. 2020. PMID: 32980620 Free PMC article.

• Anti-PL-7 antisynthetase syndrome presenting as COVID-19.

  Blake T, Noureldin B. Blake T, et al. Rheumatology (Oxford). 2021 Jul 1;60(7):e252-e254. doi: 10.1093/rheumatology/keab129. Rheumatology (Oxford). 2021. PMID: 33547779 Free PMC article. No abstract available.

• Hematologic and coagulopathy parameter as a survival predictor among moderate to severe COVID-19 patients in non- ICU ward: a single-center study at the main referral hospital in Surabaya, East Java, Indonesia.

  Bintoro SUY, Dwijayanti NMI, Pramudya D, Amrita PN, Romadhon PZ, Asmarawati TP, Bachtiar A, Hadi U. Bintoro SUY, et al. F1000Res. 2021 Aug 11;10:791. doi: 10.12688/f1000research.53803.3. eCollection 2021. F1000Res. 2021. PMID: 34904053 Free PMC article.

• Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis.

  Noonong K, Chatatikun M, Surinkaew S, Kotepui M, Hossain R, Bunluepuech K, Noothong C, Tedasen A, Klangbud WK, Imai M, Kawakami F, Kubo M, Kitagawa Y, Ichikawa H, Kanekura T, Sukati S, Somsak V, Udomwech L, Ichikawa T, Nissapatorn V, Tangpong J, Indo HP, Majima HJ. Noonong K, et al. Front Immunol. 2023 Dec 22;14:1275001. doi: 10.3389/fimmu.2023.1275001. eCollection 2023. Front Immunol. 2023. PMID: 38187378 Free PMC article. Review.

• Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

  Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Chen N, et al. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30. Lancet. 2020. PMID: 32007143 Free PMC article.

• Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

  Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Wang D, et al. JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. JAMA. 2020. PMID: 32031570 Free PMC article.

• A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

  Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen H, Hui CK, Yuen KY. Chan JF, et al. Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24. Lancet. 2020. PMID: 31986261 Free PMC article.

• Maternal and infant outcomes of full-term pregnancy combined with COVID-2019 in Wuhan, China: retrospective case series.

  Chen Y, Bai J. Chen Y, et al. Arch Gynecol Obstet. 2020 Sep;302(3):545-551. doi: 10.1007/s00404-020-05573-8. Epub 2020 Jul 21. Arch Gynecol Obstet. 2020. PMID: 32696241 Free PMC article. Review.

• Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.

  Suleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A, Demertzis Z, Hanna Z, Failla A, Dagher C, Chaudhry Z, Vahia A, Abreu Lanfranco O, Ramesh M, Zervos MJ, Alangaden G, Miller J, Brar I. Suleyman G, et al. JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270. JAMA Netw Open. 2020. PMID: 32543702 Free PMC article. Review.

• Chemokine CCL2 and its receptor CCR2 in different age groups of patients with COVID-19.

  Bagheri V, Khorramdelazad H, Kafi M, Abbasifard M. Bagheri V, et al. BMC Immunol. 2024 Oct 26;25(1):72. doi: 10.1186/s12865-024-00662-8. BMC Immunol. 2024. PMID: 39455952 Free PMC article.

• Predicting Clinical Outcomes in COVID-19 and Pneumonia Patients: A Machine Learning Approach.

  Cai K, Wang Z, Yang X, Fu W, Zhao X. Cai K, et al. Viruses. 2024 Oct 17;16(10):1624. doi: 10.3390/v16101624. Viruses. 2024. PMID: 39459956 Free PMC article.

• Genomic and epidemiological characteristics of SARS-CoV-2 in Africa.

  Lamptey J, Oyelami FO, Owusu M, Nkrumah B, Idowu PO, Adu-Gyamfi EA, Czika A, El-Duah P, Yeboah R, Sylverken A, Olasunkanmi OI, Owusu-Dabo E, Drosten C, Adu-Sarkodie Y. Lamptey J, et al. PLoS Negl Trop Dis. 2021 Apr 26;15(4):e0009335. doi: 10.1371/journal.pntd.0009335. eCollection 2021 Apr. PLoS Negl Trop Dis. 2021. PMID: 33901167 Free PMC article.

• Transcriptomic studies revealed pathophysiological impact of COVID-19 to predominant health conditions.

  Nain Z, Barman SK, Sheam MM, Syed SB, Samad A, Quinn JMW, Karim MM, Himel MK, Roy RK, Moni MA, Biswas SK. Nain Z, et al. Brief Bioinform. 2021 Nov 5;22(6):bbab197. doi: 10.1093/bib/bbab197. Brief Bioinform. 2021. PMID: 34076249 Free PMC article.

• Antigen tests for COVID-19.

  Kyosei Y, Yamura S, Namba M, Yoshimura T, Watabe S, Ito E. Kyosei Y, et al. Biophys Physicobiol. 2021 Feb 10;18:28-39. doi: 10.2142/biophysico.bppb-v18.004. eCollection 2021. Biophys Physicobiol. 2021. PMID: 33954080 Free PMC article.

1. 1. Richman DD, Whitley RJ, Hayden FG. 4th edn. ASM Press; Washington: 2016. Clinical virology.
2. 1. Ksiazek TG, Erdman D, Goldsmith CS. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348:1953–1966. - PubMed
3. 1. Kuiken T, Fouchier RAM, Schutten M. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet. 2003;362:263–270. - PMC - PubMed
4. 1. Drosten C, Günther S, Preiser W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967–1976. - PubMed
5. 1. de Groot RJ, Baker SC, Baric RS. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol. 2013;87:7790–7792. - PMC - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3